Ensign Peak Advisors, Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Ensign Peak Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.28 - $1.16 $388 - $1,611	-1,389 Reduced 0.07%	1,857,641 $613,000
Q1 2024 May 14, 2024	SELL	$1.06 - $1.67 $86,004 - $135,497	-81,136 Reduced 4.18%	1,859,030 $2.16 Million
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $1.06 Million - $1.51 Million	841,753 Added 76.63%	1,940,166 $3.28 Million
Q3 2023 Nov 13, 2023	SELL	$1.61 - $2.54 $2,907 - $4,587	-1,806 Reduced 0.16%	1,098,413 $1.99 Million
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $2.67 Million - $4.57 Million	-2,343,210 Reduced 68.05%	1,100,219 $2.05 Million
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $3,579 - $6,532	-2,983 Reduced 0.09%	3,443,429 $4.58 Million
Q4 2022 Feb 13, 2023	SELL	$1.63 - $3.52 $479,381 - $1.04 Million	-294,099 Reduced 7.86%	3,446,412 $5.82 Million
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $647,017 - $1.24 Million	294,099 Added 8.53%	3,740,511 $8.9 Million
Q1 2022 May 16, 2022	SELL	$2.83 - $8.69 $832,300 - $2.56 Million	-294,099 Reduced 7.86%	3,446,412 $13.9 Million
Q4 2021 Feb 11, 2022	BUY	$8.31 - $14.92 $30.4 Million - $54.6 Million	3,660,009 Added 4546.48%	3,740,511 $31.1 Million
Q3 2021 Nov 12, 2021	BUY	$9.15 - $13.28 $736,593 - $1.07 Million	80,502 New	80,502 $918,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.